Company: ARCHIMED
Description: ARCHIMED is a prominent investment firm with a distinct focus on the healthcare sector, operating from offices strategically located across Europe, North America, and the Asia-Pacific region. The firm's unique combination of operational, medical, scientific, and financial expertise positions ARCHIMED as both a strategic and financial partner for businesses within the healthcare industry.
ARCHIMED prioritizes several key areas, which include Biopharma Products, Consumer Health, Healthcare Information Technology, In Vitro Diagnostics, Life Science Tools, Biologic Services, Medical Technology (MedTech), and Pharma Services. By concentrating on these sectors, ARCHIMED assists its partners in internationalizing their operations, acquiring new opportunities, innovating effectively, and expanding their product and service offerings.
The firm manages a substantial asset portfolio, totaling €7 billion across its various investment funds. Notably, ARCHIMED operates the largest healthcare-only private equity fund that has been raised by a General Partner based in Europe. Since its inception, ARCHIMED has demonstrated a commitment to impact investing, both directly and through initiatives associated with its EURKA Foundation, reinforcing its dedication to fostering positive change within the healthcare landscape. Through its strategic investments and partnerships, ARCHIMED continues to play a vital role in advancing healthcare innovation and improving outcomes in the industry.
Industry: Venture Capital and Private Equity
Founded: 2014
Location: Lyon, Auvergne-Rhone-Alpes
Address: 9 rue des Cuirassiers, Lyon, Auvergne-Rhone-Alpes 69003, FR
Size: 51-200 employees